Novavax Stock News

A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax . Looking at options history for Novavax (NASDAQ: NVAX ) we detected 23 strange trades. If we consider the specifics of each trade, it is accurate to state that 39% of the investors opened trades with bullish expectations and 60% with bearish. From the overall spotted trades, 9 are puts, for a total amount of $450,442 and 14, calls, for a total amount of $818,463. What''s The Price Target? Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $70.0 to $200.0 Full story available on Benzinga.com

Novavax is now available as the first and second COVID dose for Australians aged 18 and over. Officials are hoping that the protein-based formula will provide the "extra push" some may need to get vaccinated.

A delay for Pfizer and BioNTech appears to be weighing on all vaccine stocks.

A delay for Pfizer and BioNTech appears to be weighing on all vaccine stocks.

Pfizer (PFE) and its partner BioNTech are planning to extend their rolling submission to the FDA for the authorization of Comirnaty for use in children 6 months through 4 years of age to include the t

Novavax applies for COVID-19 vaccine approval in Switzerland

Novavax Inc has submitted an application to Switzerland''s drugs regulator for the authorization of its COVID-19 vaccine in adults, the U.S. vaccine maker said on Monday.

Novavax Inc said on Monday it

President Joe Biden said it's "probably premature" for states to drop their indoor face mask requirements, as Nevada became the latest to scrap it at most places including its casinos.

A reasonably small amount of money can go a long way with these top-tier stocks.

Highlights Novavax, a protein vaccine, is now available for Aussies. The vaccine is 90% effective against mild, moderate, and severe illnesses. The Australian government has secured 51 million doses of Novavax. Novavax, the first protein vaccine, is now available for Aussies, according to a report by the Ministry of Health. The vaccine, which is the fifth to be authorised in Australia, maybe maintained for up to three months in a regular fridge, unlike other doses that must be kept at extremely low temperatures. To supplement the vaccine deployment, the Australian government has secured 51 million doses of Novavax. According to the WHO, this vaccine has a 90% effectiveness against mild, moderate, and severe illnesses. The vaccine is gradually being rolled out at community pharmacies, general practices and state clinics. How to get Novavax? As per the health ministry, Novavax will be available for bookings on health.gov.au or via your own practice, pharmacy, or state clinic. The Covid-19 Vaccine Clinic Finder also allows Australians to arrange an appointment for the Novavax vaccine.

SINGAPORE (Reuters) – Singapore’s Health Sciences Authority (HSA) said on Monday it has granted an interim authorisation for Novavax’s COVID-19 vaccine. The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said.

Singapore''s green light adds to a string of approvals for the U.S.-based vaccine maker.

SINGAPORE - The Covid-19 vaccine developed by Novavax has been approved for individuals aged 18 and above, said the Health Sciences Authority (HSA) on Monday (Feb 14). HSA had granted interim authorisation for Nuvaxovid vaccine on Feb 3, 2022 under the Pandemic Special Access Route (PSAR). The vaccination regimen comprises two five-microgram doses of Nuvaxovid to be administered 3 weeks

THE Health Sciences Authority (HSA) has granted an interim authorisation for the Nuvaxovid Covid-19 vaccine produced by Amercian biotechnology company Novavax on Feb 3, the authority said on Monday (Feb 14).